ULLA
- European University Consortium for Pharmaceutical Sciences
ULLA was founded in 1992 as a European Consortium for (Post Graduate) training in the field of Pharmaceutical Sciences. ULLA takes the name from the cities of the founding universities of the consortium, namely Uppsala, London, Leiden and Amsterdam.
ULLA has since then been extended with four more member universities and now consists of the following members:
- The Faculty of Pharmacy, University of Uppsala (Sweden)
- UCL School of Pharmacy (United Kingdom)
- The Leiden/Amsterdam Center for Drug Research, University of Leiden and the Vrije Universiteit Amsterdam (The Netherlands)
- Drug Research Academy, Faculty of Health and Medical Sciences, University of Copenhagen
- The Faculty of Pharmacy, University of Paris Sud (France)
- The Department of Pharmacy, University of Parma (Italy)
- The Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven (Belgium) - (Faculty - KULeuven)
The primary objective of the ULLA network is to enhance collaboration within education and research in pharmaceutical sciences between the European universities. The ULLA institutions are complimentary in their research and teaching missions and by coming together, possess a synergy that allows the consortium to have a greater impact on the European scene.
Another objective is to give staff and students of the member institutions increased access to the combined resources of the institutions involved.
The collaboration is specifically expressed in the following activities:
- ULLA text books "ULLA Pharmacy Series"
- ULLA summer school for PhD students every second year
- Grants forMSc students from ULLA member institutions who study as exchange students at ULLA partner institutions
- Grants for PhD students from ULLA member institutions who participate in PhD courses at ULLA partner institutions
- Grants for staff exchanges between ULLA member institutions
- ULLA conferences and workshops
The range of activities that are offered by the ULLA network is continually being developed and extended.